Find a Clinical Trial
Filter
Dompe' Reparixin study
COVID-19
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
AN2 EBO301 MAC Study
Mycobacterial disease
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Moderna mRNA 1273 study
COVID-19
All genders
0-12
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Letermovir for secondary prophylaxis for CMV disease in solid organ transplant recipients
Cytomegalovirus infection
All genders
18-75
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
A clinical trial investigating BNT113 in combination with pembrolizumab versus pembrolizumab alone for patients with a form of head and neck cancer positive for human papilloma virus 16 and expressing the protein PD-L1
Head and neck cancer
All genders
18+
Recruiting now
Cancer Center
A Long COVID-19 Observational Pilot Study Using Wearable Devices
Detection and Risk Assessment in Post COVID-19 Infection – A Long COVID-19 Observational Pilot Study
COVID-19
All genders
18+
Recruiting now
Department of Medicine, Division of Geographic Medicine + Infectious Diseases
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Squamous cell carcinoma
All genders
18+
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
EA3191
Head and neck cancer
All genders
18-79
Recruiting now
Department of Medicine, Division of Hematology/Oncology, Cancer Center
Feasibility of a new method for non-invasive monitoring of low-grade bladder cancer
Bladder cancer
All genders
18-90
Recruiting now
Department of Urology